Logan Tucker will serve as the primary contact for directing CHPA’s media strategies and tactics and coordinate with other communications department staff to manage news, events, and issues in the consumer healthcare industry.
Logan Tucker. Image courtesy of CHPA
The Consumer Healthcare Products Association (CHPA; Washington, D.C.) hired Logan Tucker as director of communications and media relations. She will serve as the primary contact for directing CHPA’s media strategies and tactics and coordinate with other communications department staff to manage news, events, and issues in the consumer healthcare industry.
“CHPA is thrilled to welcome Logan to our staff,” said Anita Brikman, CHPA’s senior vice president of communications and public affairs, in a press release. “With more than a decade of combined legislative, communications, and consulting experience, Logan’s professional background will certainly add value to our association’s communications department, while enhancing our ability to amplify the impact of CHPA’s initiatives.”
Tucker said in press release that she is honored to take the position, and “for the opportunity to highlight the important work our member companies do each day to ensure American consumers are able to pursue happier and healthier lives through responsible self-care.”
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.